Cipta Sarana Medika Tbk. vs Timah Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Timah Tbk. trades at Rp3,500 (market cap 25.92T, 33.64M 24h volume). The key difference: Timah Tbk. is far larger — about 163.9× Cipta Sarana Medika Tbk.'s market cap, and Timah Tbk. is more actively traded (33.64M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | TINS | |
|---|---|---|
Market Cap | 158.12B | 25.92T |
Volume | 8.21M | 33.64M |
Lot | 82.15K | 336.36K |
Turnover | 515.2M | 118.14B |
Average Price | 62.72 | 3,512.42 |
Value | 515.2M | 118.14B |
Indicative Equilibrium Price | 63 | 3,500 |
Indicative Equilibrium Volume | 1.33K | 12.86K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Timah Tbk (Company) was officially establish by Imas Fatimah, SH by Notarial Deed No.1 dated 2 August 1976. The Company represents a merger of three Dutch Mining companies with operations in Indonesia. The Company’s registration statement in offer 50.330.000 new B class shares at par value of Rp. 500 per share in Indonesia was effective on 27 September 1995. In relation to the offering the new shares, the Government of the Republic of Indonesia also offered 125,825,000 B class shares which were represented by 12,582,500 GDR (each GDR representing 10 B class shares) to the public outside Indonesia. Gross profit for 1999 stand at Rp 751 billion, a figure 45% lower than that achieved in 1998, when gross profits reached Rp 1,362 billion.
Read more on TINS →